Volumetric absorptive microsampling coupled with hybridization LC-MS/MS for quantitation of antisense oligonucleotides

Bioanalysis. 2023 Sep;15(18):1115-1128. doi: 10.4155/bio-2023-0092. Epub 2023 Sep 8.

Abstract

Background: Volumetric absorptive microsampling has emerged as a less invasive alternative to venous sampling for small-molecule pharmacokinetic studies, but its application to novel therapeutics such as antisense oligonucleotides (ASOs) is not well-established. Results: A workflow was developed using Mitra microsampling coupled with hybridization LC-MS/MS for accurate determination of fomivirsen, a 21-mer ASO, in human blood. Quantitative recovery was achieved regardless of blood hematocrit level or microsample age by implementing impact-assisted extraction. A thorough method evaluation confirmed sensitivity, linearity, precision/accuracy, matrix effect, metabolite interference and four months of microsample stability. Conclusion: The combined impact-assisted extraction and hybridization LC-MS/MS workflow demonstrated the successful quantitation of fomivirsen, establishing the validity and applicability of the approach for ASO drug candidates.

Keywords: Mitra® volumetric absorptive microsampling; antisense oligonucleotides; fomivirsen; hybridization LC–MS/MS; impact-assisted extraction.

MeSH terms

  • Chromatography, Liquid
  • Humans
  • Nucleic Acid Hybridization
  • Oligonucleotides, Antisense*
  • Tandem Mass Spectrometry*

Substances

  • fomivirsen
  • Oligonucleotides, Antisense